Signal sequence deletion and fusion to tetanus toxoid epitope augment antitumor immune responses to a human carcinoembryonic antigen (CEA) plasmid DNA vaccine in a murine test system
- 29 April 2003
- journal article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 10 (5) , 365-376
- https://doi.org/10.1038/sj.cgt.7700574
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Colorectal carcinoma evidence for circulating CEA-anti-CEA complexesCancer, 2006
- The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissuesSeminars in Cancer Biology, 1999
- Can immunotherapy by gene transfer tip the balance against colorectal cancer?Gut, 1998
- The proteasome system: a neglected tool for improvement of novel therapeutic strategies?Gene Therapy, 1998
- Mimicking the humoral immune response in vitro results in antigen‐specific isotype switching supported by specific autologous T helper cells: generation of human HIV‐1‐neutralizing IgG monoclonal antibodies from naive donorsEuropean Journal of Immunology, 1995
- Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral ProteinScience, 1993
- Antitumor Activity and Immune Responses Induced by a Recombinant Carcinoembryonic Antigen-Vaccinia Virus VaccineJNCI Journal of the National Cancer Institute, 1992
- An idiotypic replica of carcinoembryonic antigen inducing cellular and humoral responses directed against human colorectal tumoursInternational Journal of Cancer, 1992
- NCA: A DIFFERENTIATION ANTIGEN OF MYELOPOIETIC CELLS IN HUMANS AND HOMINOID MONKEYSAnnals of the New York Academy of Sciences, 1983
- Further investigations of circulating antibodies in colon cancer patients: On the autoantigenicity of the carcinoembryonic antigenInternational Journal of Cancer, 1971